News

Balt receives IDE approval from the FDA to begin the STEM Trial

Balt announced today it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin The Squid Trial for the Embolization of the Middle meningeal artery (STEM) for the treatment of chronic Sub-Dural Hematoma.

Discover the Press Release

Other News

News
Feb 09, 2024

STEM Clinical Trial

Read More
STEM Clinical Trial
News
Jan 09, 2024

BALT in the spotlight: media recognition for our stroke research work

Read More
BALT in the spotlight: media recognition for our stroke research work
News
Oct 10, 2023

Florence Leroy joins Balt’s Executive Team as VP Global Human Resources

Read More
Florence Leroy joins Balt’s Executive Team as VP Global Human Resources
News
Oct 08, 2023

Balt at the 20km of Paris

Read More
Balt at the 20km of Paris
News
May 20, 2023

Balt at Lisa Forever race

Read More
Balt at Lisa Forever race
News
Mar 08, 2023

Balt at the half marathon of Paris 2023

Read More
Balt at the half marathon of Paris 2023
Previous Next
Close
Balt Lab

Contact Us

Need more information? We are here to help.

    *Required

    EN